IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 48 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $30 | -99.9% | 87,412 | +1.0% | 0.00% | – |
Q3 2022 | $32,000 | -17.9% | 86,537 | -0.1% | 0.00% | – |
Q2 2022 | $39,000 | -9.3% | 86,662 | 0.0% | 0.00% | – |
Q1 2022 | $43,000 | -12.2% | 86,662 | 0.0% | 0.00% | – |
Q4 2021 | $49,000 | -44.9% | 86,662 | 0.0% | 0.00% | – |
Q3 2021 | $89,000 | -13.6% | 86,662 | 0.0% | 0.00% | – |
Q2 2021 | $103,000 | +114.6% | 86,662 | +130.9% | 0.00% | – |
Q1 2021 | $48,000 | -50.5% | 37,537 | +40.8% | 0.00% | – |
Q4 2020 | $97,000 | +120.5% | 26,662 | +27.5% | 0.00% | – |
Q3 2020 | $44,000 | +18.9% | 20,912 | -0.0% | 0.00% | – |
Q2 2020 | $37,000 | +37.0% | 20,915 | 0.0% | 0.00% | – |
Q1 2020 | $27,000 | -28.9% | 20,915 | -0.1% | 0.00% | – |
Q4 2019 | $38,000 | -36.7% | 20,940 | 0.0% | 0.00% | – |
Q3 2019 | $60,000 | +9.1% | 20,940 | 0.0% | 0.00% | – |
Q2 2019 | $55,000 | +14.6% | 20,940 | +9.3% | 0.00% | – |
Q1 2019 | $48,000 | -9.4% | 19,150 | 0.0% | 0.00% | – |
Q4 2018 | $53,000 | -68.8% | 19,150 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $170,000 | – | 19,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |